市場調査レポート

商品コード

1596859

医療用食品の市場規模、シェア、成長分析：投与経路別、製品別、販売チャネル別、用途別、地域別 - 産業予測、2024年～2031年

Medical Foods Market Size, Share, Growth Analysis, By Route of Administration, By Product, By Sales Channel, By Application, By Region -Industry Forecast 2024-2031.

出版日: 2024年11月18日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医療用食品の世界市場規模は、2022年に226億米ドルと評価され、2023年の237億8,000万米ドルから2031年には356億7,000万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは5.20％で成長する見通しです。

医療用食品市場は、アルツハイマー、ADHD、骨粗鬆症、変形性関節症、各種中枢神経障害などの慢性疾患の有病率の上昇に牽引され、大きな成長を遂げています。さらに、医療専門家は、睡眠障害、うつ病、線維筋痛症、PTSDなどの症状に対してアミノ酸ベースの経腸栄養剤を推奨しており、特定の栄養ニーズや消化器系の問題を抱える患者向けにこれらの製品が調整されていることを強調しています。この拡大は、医薬品開発の進歩や疾患特異的製剤のイントロダクションよってさらに促進されています。ネスレのような業界リーダーは、個別化された臨床栄養ソリューションの創出の最前線に立っており、それは糖尿病管理のためのMetanxやうつ病に対処するためのデプリンのような製品によって証明されています。医療用食品は、パーキンソン病やアルツハイマー病などの病態を効果的に管理するために、医学的管理下で投与される医薬品と栄養補助食品の要素を組み合わせたハイブリッドな存在として、ますます認知されるようになっています。医療用食品と従来の栄養補助食品との違いは、医療用食品が受ける厳格な臨床テストにあり、そのためには医療用食品が対処するためにデザインされた病態を十分に理解する必要があります。ヘルスケアプロバイダーが患者の栄養ニーズと健康状態を評価するにつれ、医療用食品はますます推奨されるようになり、消費者の間で知名度と受容性が高まっています。このような要因が、今日のヘルスケアシーンにおける医療用食品の人気と需要の急上昇につながっているのです。

市場概要
慢性腎臓病
軽度肝性脳症
化学療法誘発性下痢
病原体関連感染症
糖尿病性神経障害
ADHD
うつ
アルツハイマー病
栄養不足
希少疾患
- チロシン血症
- 好酸球性食道炎
- FPIES
- フェニルケトン尿症
- MSUD
- ホモシスチン尿症
- その他
傷の治癒
その他

医療用食品市場：地域別

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東およびアフリカ
- アラブ首長国連邦諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Danone
Nestle
Abbott
Targeted Medical Pharma Inc.（Physician Therapeutics LLC, a division of the company）
Primus Pharmaceuticals Inc.
Fresenius Kabi AG
Kate Farms
Ajinomoto Cambrooke
Nutricia North America
GlaxoSmithKline
B. Braun Medical Inc.
BioCare
NutriScience Innovations
Ajinomoto Health & Nutrition
Baxter International
Fresenius Kabi

結論と推奨事項

Product Code: SQMIG35I2345

Global Medical Foods Market size was valued at USD 22.60 billion in 2022 and is poised to grow from USD 23.78 billion in 2023 to USD 35.67 billion by 2031, growing at a CAGR of 5.20% during the forecast period (2024-2031).

The market for medical foods is experiencing significant growth, driven by the rising prevalence of chronic diseases such as Alzheimer's, ADHD, osteoporosis, osteoarthritis, and various central nervous system disorders. Additionally, medical professionals recommend amino acid-based enteral nutrition for conditions like sleep disorders, depression, fibromyalgia, and PTSD, highlighting the tailored nature of these products for patients with specific nutritional needs or digestive issues. This expansion is further fueled by advancements in drug development and the introduction of disease-specific formulations. Industry leaders, such as Nestle, have been at the forefront of creating personalized clinical nutrition solutions, evidenced by their products like Metanx for diabetes management and Deplin for addressing depression. Medical foods are increasingly recognized as hybrid entities that combine elements of pharmaceuticals and dietary supplements, administered under medical supervision to manage conditions such as Parkinson's and Alzheimer's disease effectively. The differentiation between medical foods and conventional nutritional supplements lies in the rigorous clinical testing that medical foods undergo, necessitating a thorough understanding of the conditions they are designed to address. As healthcare providers assess patients' nutritional needs and health conditions, medical foods are being increasingly recommended, enhancing their visibility and acceptance among consumers. These factors collectively contribute to the surging popularity and demand for medical foods in today's healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Foods market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Foods Market Segmental Analysis

Global Medical Foods Market is segmented into Route of Administration, Product, Sales Channel, Application, and region. By animal type, the market is classified into Oral, and Enteral. Depending on the product, it is categorized into Powder, Pills, Liquid, and Other. According to end user, the market is divided into Online Sales, Retail Sales, and Institutional Sales. By Application, the market is segmented into Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Medical Foods Market

The global Medical Foods market is driven by the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and metabolic disorders. As these health issues become more widespread, there is a growing need for dietary interventions tailored to individual health requirements. Medical foods play a crucial role in addressing these dietary needs, helping patients manage their symptoms effectively while promoting better health outcomes. By enhancing overall well-being and improving quality of life, the demand for these specialized nutritional products is set to rise significantly, underscoring the vital importance of medical foods in contemporary healthcare regimes.

Restraints in the Global Medical Foods Market

One of the key restraints in the Global Medical Foods market is the lack of education and awareness among medical professionals, patients, and caregivers regarding the significance and benefits of medical foods. Without effective communication and educational efforts, the acceptance and adoption of these products can be hindered. Many healthcare providers may not fully grasp the distinctions between medical foods, dietary supplements, and conventional foods, which can negatively impact prescription practices and ultimately affect patient outcomes. Therefore, enhancing knowledge and understanding in this area is crucial for improving the utilization of medical foods and ensuring they are appropriately integrated into patient care.

Market Trends of the Global Medical Foods Market

The Global Medical Foods market is experiencing significant growth driven by an increasing emphasis on chronic disease management, highlighting the pivotal role of medical foods in treating conditions such as diabetes, Alzheimer's disease, and gastrointestinal disorders. As healthcare systems prioritize preventative approaches and integrated care models, the demand for specialized nutritional products designed to target metabolic pathways and address specific dietary deficiencies is escalating. This trend underscores a transformative shift towards holistic treatment methodologies that combine medical and nutritional therapy, making medical foods a crucial component in the strategy to enhance patient outcomes and reduce healthcare costs globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index
Pricing Analysis

Global Medical Foods Market Size by Route of Administration & CAGR (2024-2031)

Market Overview
Oral
Enteral

Global Medical Foods Market Size by Product & CAGR (2024-2031)

Market Overview
Powder
Pills
Liquid
Other

Global Medical Foods Market Size by Sales Channel & CAGR (2024-2031)

Market Overview
Online Sales
Retail Sales
Institutional Sales

Global Medical Foods Market Size by Application & CAGR (2024-2031)

Market Overview
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhoea
Pathogen Related Infections
Diabetic Neuropathy
ADHD
Depression
Alzheimer's Disease
Nutritional Deficiency
Orphan Diseases
- Tyrosinemia
- Eosinophilic Esophagitis
- FPIES
- Phenylketonuria
- MSUD
- Homocystinuria
- Others
Wound Healing
Others

Global Medical Foods Market Size & CAGR (2024-2031)

North America, (Route of Administration, Product, Sales Channel, Application)
- US
- Canada
Europe, (Route of Administration, Product, Sales Channel, Application)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Route of Administration, Product, Sales Channel, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Route of Administration, Product, Sales Channel, Application)
- Brazil
- Rest of Latin America
Middle East & Africa, (Route of Administration, Product, Sales Channel, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Danone
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Primus Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kate Farms
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Cambrooke
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutricia North America
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NutriScience Innovations
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Health & Nutrition
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

医療用食品の市場規模、シェア、成長分析：投与経路別、製品別、販売チャネル別、用途別、地域別 - 産業予測、2024年～2031年

Medical Foods Market Size, Share, Growth Analysis, By Route of Administration, By Product, By Sales Channel, By Application, By Region -Industry Forecast 2024-2031.

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

医療用食品市場：投与経路別

医療用食品市場：製品別

医療用食品市場：販売チャネル別

医療用食品市場：用途別